SCHEMBL31691370

SCHEMBL31691370

O=C(O)c1ccc(Cn2cccn2)c(C2CCO2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.52
▸ HDAC1 Q13547 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ KDM5A P29375 1/20 0.39
▸ KDM2B Q8NHM5 1/20 0.39
▸ KDM4C Q9H3R0 1/20 0.39
▸ KDM5B Q9UGL1 1/20 0.39
▸ DRD3 P35462 1/20 0.39
▸ BRD4 O60885 1/20 0.38
▸ ADRA1A P35348 1/20 0.38
▸ HRH3 Q9Y5N1 3/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ GAA P10253 1/20 0.37
▸ KLKB1 P03952 3/20 0.36
▸ GLP1R P43220 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31172740 0.87 HTT (0.55) HTTHDAC1HDAC6KDM5AKDM2B
SCHEMBL31691311 0.87 HDAC1 (0.40) HTTHDAC1HDAC6HRH3MEN1
SCHEMBL31691464 0.85 HTT (0.53) HTTHDAC1HDAC6KDM5AKDM2B
SCHEMBL31689713 0.84 HTT (0.52) HTTHDAC1HDAC6KDM5AKDM2B
SCHEMBL31691459 0.84 HTT (0.52) HTTHDAC1HDAC6KDM5AKDM2B
SCHEMBL31691283 0.76 HTT (0.60) HTTHDAC1HDAC6KDM5AKDM2B
SCHEMBL31691366 0.76 HTT (0.60) HTTHDAC1HDAC6KDM5AKDM2B
SCHEMBL31691462 0.76 HTT (0.60) HTTHDAC1HDAC6KDM5AKDM2B
SCHEMBL31691247 0.76 HTT (0.60) HTTHDAC1HDAC6KDM5AKDM2B
SCHEMBL31691458 0.75 HTT (0.55) HTTHDAC1HDAC6KDM5AKDM2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250304535-A1 KAT6 Inhibitors BEIGENE SWITZERLAND GMBH (CH) 2025-10-02 — — US disclosed
WO-2025201504-A1 KAT6 INHIBITORS BEIGENE (SUZHOU) CO., LTD. (CN) 2025-10-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250304535-A1 KAT6 Inhibitors KAT6A, KAT6B, KAT2A HTT 75/4885HDAC1 12/4885HDAC6 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback